April 29, 2026

DNS Africa Resource Center

..sharing knowledge.

China's First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of SYCUME® for the Treatment of Thyroid Eye Disease – Yahoo Finance


China’s First IGF-1R Monoclonal Antibody: Innovent Announces NMPA approval of SYCUME® for the Treatment of Thyroid Eye Disease  Yahoo Finance
source

About The Author